Brickell Kiri L, Leverenz James B, Steinbart Ellen J, Rumbaugh Malia, Schellenberg Gerard D, Nochlin David, Lampe Thomas H, Holm Ida E, Van Deerlin Vivianna, Yuan Wuxing, Bird Thomas D
Neurological Foundation of New Zealand, New Zealand.
J Neurol Neurosurg Psychiatry. 2007 Oct;78(10):1050-5. doi: 10.1136/jnnp.2006.113803. Epub 2007 Jul 5.
Neuropathological examination of both individuals in a monozygotic (MZ) twin pair with Alzheimer's disease (AD) is rare, especially in the molecular genetic era. We had the opportunity to assess the concordance and discordance of clinical presentation and neuropathology in three MZ twin pairs with AD.
The MZ twins were identified and characterised by the University of Washington Alzheimer's Disease Research Center. We reviewed the available clinical and neuropathological records for all six cases looking specifically for concordance and discordance of clinical phenotype, neuritic amyloid plaques (NP), neurofibrillary tangles (NFT) and Lewy related pathology (LRP).
Discordance in age of onset for developing AD in the MZ twins varied from 4 to 18 years. Clinical presentations also differed between twins. One twin presented with a dementia with Lewy Body clinical syndrome while the other presented with typical clinical AD. Neuropathology within the MZ twin pairs was concordant for NP and NFT, regardless of duration of disease, and was discordant for LRP. This difference was most marked in the late onset AD twin pair. One pair was found to have a mutation in presenilin-1 (PS1) (A79V) with remarkably late onset in a family member.
MZ twins with AD can vary considerably in age of onset, presentation and disease duration. The concordance of NP and NFT pathological change and the discordance of LRP support the concept that, in AD, the former are primarily under genetic control whereas the latter (LRP) is more influenced by disease duration and environmental factors. The A79V mutation in PS1 can be associated with very late onset of dementia.
对同卵双胞胎中患阿尔茨海默病(AD)的两人进行神经病理学检查的情况较为罕见,尤其是在分子遗传学时代。我们有机会评估三对患AD的同卵双胞胎在临床表现和神经病理学方面的一致性和不一致性。
同卵双胞胎由华盛顿大学阿尔茨海默病研究中心识别并进行特征描述。我们查阅了所有六例患者的现有临床和神经病理学记录,特别关注临床表型、神经炎性淀粉样斑块(NP)、神经原纤维缠结(NFT)和路易体相关病理学(LRP)的一致性和不一致性。
同卵双胞胎中患AD的发病年龄差异为4至18岁。双胞胎之间的临床表现也有所不同。其中一对双胞胎表现为路易体痴呆临床综合征,而另一对表现为典型的临床AD。同卵双胞胎对中,无论病程长短,NP和NFT的神经病理学表现是一致的,而LRP则不一致。这种差异在晚发性AD双胞胎对中最为明显。发现一对双胞胎中的一名家庭成员在早老素-1(PS1)基因上存在突变(A79V),且发病非常晚。
患AD的同卵双胞胎在发病年龄、表现和病程方面可能有很大差异。NP和NFT病理变化的一致性以及LRP的不一致性支持了这样一种观点,即在AD中,前者主要受遗传控制,而后者(LRP)更多地受病程和环境因素的影响。PS1基因中的A79V突变可能与痴呆的极晚发病有关。